Aug 31, 2026

The Semaglutide to Tirzepatide Dose Conversion, Explained

Medically reviewed by:
A woman working out outside, taking a moment to breathe.
The Big Picture

You know that things in life don’t always turn out the way you want them to (think: those jeans you bought online). Well, that can happen with groundbreaking weight loss medications, too. They have worked for a whole lot of people, but if semaglutide hasn’t worked for you, you may be thinking about switching to tirzepatide.

That may naturally lead you to wondering about the right semaglutide to tirzepatide dose conversion, especially if you’ve come across confusing charts online. You don’t need to figure this all out by yourself: A clinician well-versed in midlife health issues, like one at Midi Health, can help you every step of the way. And this guide will give you the top-level info you need to know.

If you’re taking semaglutide but need to make a change, you’re probably going through a lot of emotions. 

Maybe your weight loss has plateaued, you’re having trouble tolerating the side effects, or you’re having issues with cost or availability. You may be disappointed and frustrated, and it may feel unfair—especially if you know tons of other women who are happy with the medication.

You may also have lots of questions, particularly if you’re thinking about switching to tirzepatide. A common one that pops up: What does a semaglutide to tirzepatide dose conversion actually involve?

When it comes to doses, there’s no fixed one-to-one conversion between the two medications, and switching is individualized and clinician-directed. Midi clinicians take careful considerations into account to make sure the transition is a smooth success. 

Here’s what you need to know about switching weight loss medications and how a clinician trained in midlife health issues can help with the right semaglutide to tirzepatide dose conversion. 

Semaglutide vs. Tirzepatide: How Are They Different?

Semaglutide and tirzepatide are medications prescribed for diabetes treatment and weight loss. 

When semaglutide is prescribed for weight loss, the brand name is Wegovy. For diabetes, it’s Ozempic. When tirzepatide is prescribed for weight loss, the brand name is Zepbound. For diabetes, it’s Mounjaro.

Although both are medications for weight loss and diabetes, they work in slightly different ways:

  • Semaglutide is a GLP-1 receptor agonist, meaning it targets GLP-1 receptors throughout the body to improve blood sugar management and regulate appetite.
  • Tirzepatide is a dual GLP-1/GIP receptor agonist, meaning in addition to its GLP-1 benefits, it activates GIP receptors, which are also involved in blood sugar management and appetite and satiety. (Activating these GIP receptors also appears to help counter or buffer the nausea induced by GLP-1 signally—so there’s less nausea with tirzepatide.) Due to this dual mechanism, tirzepatide has been found to result in greater weight loss than semaglutide. 

A module that says "Midi patients lost an average of 16 lbs. after at least 6 months of weight management care" with a disclaimer and a "book a visit" button.

Why There's No Exact Semaglutide to Tirzepatide Dose Conversion

Both semaglutide and tirzepatide are dosed differently from the start, and there’s no one-to-one milligram (mg) equivalence between the two drugs—which is why there isn’t an official semaglutide to tirzepatide dosage chart.

But if you’re searching online, you might run into an Ozempic to Mounjaro conversion chart that seems to lay out all these dosing details. Generally, these conversion charts offer rough comparisons from various sources, and they aren’t medically guided. This doesn’t mean that you can’t switch from one medication to the other—but it does mean that you shouldn’t approach this on your own. 

Instead, work with a healthcare professional, like a Midi clinician, who can factor in your specific situation and help you switch from semaglutide to tirzepatide safely.

Image of Anthem, Cigna, BCBS, Aetna, UnitedHealthcare, and Health Net logos with headline "Virtual Visits, Expert Clinicians, covered by insurance"

How Do Clinicians Approach Switching from Semaglutide to Tirzepatide?

Your clinician will take four main factors into consideration when you switch from semaglutide to tirzepatide: 

  • your weight loss response to semaglutide
  • how well you tolerated the medication
  • any existing health conditions you have (such as diabetes, heart disease, and liver disease)
  • your clinician’s own judgment and expertise 

One of the most important factors is how well you tolerated semaglutide. If you experienced side effects, Midi clinicians generally recommend starting at lower equivalent doses to help make tirzepatide more tolerable. 

For example, if you tolerated semaglutide well on a dose of 1 mg, the suggested tirzepatide start dose may be 5 mg. However, if side effects were an issue, your clinician may recommend a step-down dose on tirzepatide, suggesting 2.5 mg. (This is just an example, not a specific rule.)

Gradually, your clinician will prescribe a higher tirzepatide dose, until you reach a tolerable, effective dose. On tirzepatide, your dose will generally increase once every 4 weeks, based on your tolerability and response. 

As for timing, the switch from semaglutide to tirzepatide is typically seamless. You’ll take your final dose of semaglutide, and then the following week, you’ll take your first dose of tirzepatide. You don’t need a “wash out” period in between the two, and you can keep your same injection day for convenience.

What to Expect During the Switch

If you’ve already been taking semaglutide, you’re probably aware of common side effects like nausea. These side effects tend to be strongest when starting a new medication or when your dose has been adjusted. GI side effects can also happen when switching from one medication to another.

Your clinician can advise you on how to approach the transition from semaglutide to tirzepatide based on your prior experience. For example, if you experienced some unpleasant semaglutide side effects, your clinician may also send a prescription for an anti-nausea and anti-vomiting medication called ondansetron (Zofran) ahead to your pharmacy, so you can have it on hand if needed.

Another thing to be aware of during the transition: Your weight and appetite might change as the new medication takes effect. Results take time, and a past plateau on semaglutide doesn’t predict how you’ll react to tirzepatide. These are different medications, and responses are individual. 

Track your symptoms and other changes as you make this transition, so you can share them with your clinician. Together, you can set realistic expectations, as well as a timeline for dose escalation and results. 

Safety, Side Effects, and What to Monitor

Any medication comes with potential side effects. The most common side effects of tirzepatide are similar to semaglutide: nausea, diarrhea, vomiting, constipation, and, to a lesser degree, abdominal pain, heartburn, skin reactions at the injection, and fatigue. 

Some side effects warrant a call to your clinician immediately, including severe dizziness, shakiness, or sweating, which can be signs of hypoglycemia (low blood sugar). 

No matter which of the medications you’re taking, you should also see a healthcare professional ASAP if you have:

  • severe stomach pain
  • severe vomiting
  • fever
  • clay-colored stools
  • very rapid heartbeat
  • fainting
  • severe rash
  • an inability to drink or eat

If you have an allergic reaction that includes difficulty breathing, this may be a sign of anaphylaxis. Call 911.

Stay in touch with your clinician during the switch from semaglutide to tirzepatide—they’ll be an invaluable resource of helpful, individualized tips. 

Midlife and Menopause Considerations With GLP-1 Switches

During midlife, it’s incredibly common to notice changes in your weight and body shape. The menopausal transition can contribute to weight gain, due to hormonal changes that affect metabolism and appetite, muscle loss, a change in habits, increased stress, sleep problems, and more. 

Interestingly enough, research suggests that women in their menopausal years may have a greater benefit from GLP-1 medications. One study review found that GLP-1s were associated with greater weight loss and reduced abdominal fat among women in menopause and postmenopause. 

Menopause can also complicate weight loss treatment because some of its symptoms—like low energy, appetite changes, or fatigue—can overlap with medication side effects, sometimes making it hard to tell one from the other. 

A menopause-informed clinician, who understands the interplay between changing hormones and weight, can help personalize your care. Midi clinicians understand how to best coordinate weight loss medications and treatments like hormone therapy. 

Midi clinicians headshot

When to Talk With a Clinician About Switching

For all the fanfare of GLP-1s, sometimes they don’t work in the way we expect. Consider talking with a clinician about switching from semaglutide to tirzepatide if you:

  • have plateaued in your weight loss
  • have hard-to-tolerate side effects 

Ask your clinician about the starting dose they’d recommend, the best time to start, a titration (dose increase) plan, and ongoing monitoring. People react to weight loss medications in different ways, and that’s why individualized GLP-1 care is needed for the best results. The goal is for your quality-of-life to improve on these medications—not get worse.

If you need to transition from one weight loss medication to another, know that Midi clinicians are here to help. Together, you and your clinician can map out a personalized, supervised transition plan. Book a visit to learn more.

Key Takeaways

  • Switching from semaglutide to tirzepatide for diabetes or weight loss treatment is possible, and many women do this if they’re not seeing results or tolerating side effects well.
  • There is not a standardized conversion chart between semaglutide and tirzepatide. The dose you start at depends on tolerability and efficacy of the initial medication and clinician judgment based on your individualized needs. 
  • Hormonal changes during menopause matter in your weight loss journey, including when you’re taking GLP-1s. Having a clinician who is knowledgeable in menopause and midlife weight challenges is key for success.
  • Consult a clinician before switching from semaglutide to tirzepatide when you experience a weight loss plateau, have hard-to-tolerate side effects, or deal with access or affordability issues. Your clinician can guide you on the proper dosing, titration, and schedule.

Frequently Asked Questions (FAQs)

Is there a one-to-one dose conversion from semaglutide to tirzepatide?

There is no one-to-one dose conversion. Semaglutide and tirzepatide each have their own dosing schedules. That’s why it’s not recommended that you try to do this on your own, but instead work with an experienced clinician to make the switch.

What tirzepatide dose is roughly comparable to 1 mg of semaglutide?

If you are currently taking 1 mg of semaglutide, many clinicians may recommend starting with a 5 mg dose of tirzepatide, provided you tolerated semaglutide. But again, the dosing should be individualized to your situation.

Do you start tirzepatide at a low dose even if you were on a high semaglutide dose?

These decisions are based on clinician discretion. They’ll consider the dose of semaglutide you were taking and how effective and tolerable it was for you. If you didn't tolerate semaglutide well, your clinician will likely start you on a lower dose before slowly increasing over time. But remember: These are two different medications, and you may not need as high a dose of tirzepatide, since it has the benefit of acting on GIP as well as GLP-1.

How long should you wait between your last semaglutide dose and starting tirzepatide?

Follow your clinician’s recommendation. In general, you will take your final dose of semaglutide and then start tirzepatide 1 week later, on the same injection day.

Why might a midlife woman switch from semaglutide to tirzepatide?

A midlife woman might choose to switch from semaglutide to tirzepatide if she is not getting the results she wants, not tolerating the side effects, or running into cost or accessibility issues that make it hard to fill the medication.

How Midi Can Help You

If you’re in perimenopause or menopause and want guidance from clinicians who specialize in women’s midlife health, book a virtual visit with Midi today. 

‍Hormonal change is at the root of dozens of symptoms women experience in the years before and after their period stops. 

Our trained menopause specialists can help you connect the dots to guide you towards safe, effective solutions.

‍Whether you need personalized guidance or a prescription routine to tackle symptoms—including vaginal dryness and irritation, brain fog, hot flashes, sleep trouble, mood swings, and weight gain—we’ve got you covered.

EDITORIAL STANDARDS

Midi’s mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story. We believe that starts with education, to help all of us understand our always-changing bodies and health needs. Our core values guide everything we do, including standards that ensure the quality and trustworthiness of our content and editorial processes. We’re committed to providing information that is up-to-date, accurate, and relies on evidence-based research and peer-reviewed journals. For more details on our editorial process, see here.